ClinicalTrials.Veeva
Menu

Find clinical trials for Colon Cancer in Chicago, IL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Colorectal Cancer
Colonic Cancer
Cancer
Neoplasm Metastasis
Adenocarcinoma
Lung Cancer
Non-Small-Cell Lung Carcinoma

Colon Cancer trials near Chicago, IL, USA:

Pembrolizumab in Early Stage Colon Cancer

drug. The purpose of this study is to target early stage colon cancer before it has developed resistance to immunotherapy....

Enrolling
Colon Cancer
Procedure: Surgery
Drug: Pembrolizumab

Phase 2

The University of Chicago
The University of Chicago

Chicago, Illinois, United States and 1 other location

(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...

Enrolling
Colonic Neoplasms
Neoplasms, Colon
Drug: FOLFOX
Biological: Dostarlimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Chicago, Illinois, United States and 212 other locations

and pembrolizumab) given together for the treatment of colorectal cancer that:* is metastatic (spread to other parts of the body);* has the ...

Enrolling
Metastatic Colorectal Cancer
Biological: Pembrolizumab
Biological: Cetuximab

Phase 2

Pfizer
Pfizer

Chicago, Illinois, United States and 108 other locations

This is an open-label, multicenter Phase 1 study to evaluate safety, tolerability and preliminary efficacy of oral LY3410738 in patients with isocitr...

Active, not recruiting
Glioma
Chondrosarcoma
Drug: LY3410738
Drug: Gemcitabine

Phase 1

Lilly
Lilly

Chicago, Illinois, United States and 32 other locations

to participants with advanced solid tumors, including rearranged during transfection (RET)-fusion-positive solid tumors, medullary thyroid cancer...

Enrolling
Colon Cancer
Medullary Thyroid Cancer
Drug: LOXO-292

Phase 1, Phase 2

Loxo Oncology
Loxo Oncology

Chicago, Illinois, United States and 83 other locations

the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...

Enrolling
Stage III Colon Cancer
Drug: mFOLFOX6 3-6 month
Device: Signatera test

Phase 2, Phase 3

NRG Oncology

Chicago, Illinois, United States and 831 other locations

A Phase 1 SAD/MAD dose escalation and expansion study to determine the safety and effectiveness of ²¹²Pb-DOTAM-GRPR1 in subjects with various GRPR-ex...

Enrolling
Breast Cancer
Colon Cancer
Drug: ²¹²Pb-DOTAM-GRPR1

Phase 1

Orano Med

Chicago, Illinois, United States and 3 other locations

This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 in combination with TNO155 in pat...

Active, not recruiting
Metastatic Cancer
Advanced Cancer
Drug: TNO155
Drug: MRTX849

Phase 1, Phase 2

Mirati Therapeutics
Mirati Therapeutics

Chicago, Illinois, United States and 11 other locations

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody ta...

Enrolling
Malignant Pleural Mesothelioma
Colorectal Adenocarcinoma
Drug: 5-fluorouracil
Drug: Irinotecan

Phase 1

Inhibrx

Chicago, Illinois, United States and 18 other locations

plus BSC in participants with refractory metastatic colorectal cancer (mCRC). 691 participants were randomized to one of the following treat...

Active, not recruiting
Metastatic Colorectal Cancer
Metastatic Colon Cancer
Drug: Fruquintinib
Drug: Placebo

Phase 3

HUTCHMED
HUTCHMED

Chicago, Illinois, United States and 152 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems